Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection - Wikidata - wikimedia - TriplyDB

Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection

Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection

http://www.wikidata.org/entity/Q30419079

about

Bacterial Extracellular Polysaccharides in Biofilm Formation and Function Will there ever be a universal Staphylococcus aureus vaccine?Microbial biofilm formation: a need to act A comprehensive analysis of in vitro and in vivo genetic fitness of Pseudomonas aeruginosa using high-throughput sequencing of transposon libraries Identification of Poly-N-acetylglucosamine as a Major Polysaccharide Component of the Bacillus subtilis Biofilm Matrix Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.Fitness cost of antibiotic susceptibility during bacterial infection.An Oxygen-Sensing Two-Component System in the Burkholderia cepacia Complex Regulates Biofilm, Intracellular Invasion, and Pathogenicity.Allosteric activation of exopolysaccharide synthesis through cyclic di-GMP-stimulated protein-protein interaction.The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes.Combating multidrug-resistant Gram-negative bacterial infections.Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG Therapeutic antibodies and infectious diseases, Tours, France, November 20-22, 2012.Linear and cyclic oligo-β-(1→6)-D-glucosamines: Synthesis, conformations, and applications for design of a vaccine and oligodentate glycoconjugates Structural investigation of human S. aureus-targeting antibodies that bind wall teichoic acid

P2860

Q26799809-95155A63-D0A7-4C26-9E49-49822D82CA5C Q26824837-0BC73F69-896E-4EDB-BFE3-DE0F366AD14A Q27007396-A09596A5-8F17-434E-AA5D-83C5EABA0625 Q28493193-4C46C8C5-C973-48A8-9B2F-4E7EA3ED59DB Q30375706-79C8567A-F391-4CC4-B303-6F7C155B42D0 Q30415823-3891E877-A1D5-4435-8A9C-D84AA6C78BF6 Q34450382-1C6A90A1-1C11-4FF2-BB2F-EBED58B04B8B Q35707529-6509468E-A783-4D74-B586-9B29690AAC2D Q36238452-641ACE93-621E-4B68-875B-86CE94072AE7 Q36595823-B85910C0-F6EB-4EB2-884B-EE0DA82F5190 Q36646787-5953AC9F-A35D-4C0D-A304-6758E9F06188 Q36684178-A64B4986-37F3-4CA0-8E98-DA828A0A1F33 Q38035276-7A74E269-3C49-4540-84D3-7A1929493298 Q38161570-8A8E218B-C6A3-4EBD-B0CE-BD4C160B3218 Q38247296-7D554BB8-421A-4FC0-8658-6F15BE8A23E8 Q38849929-BA9FBF84-53CC-4E8F-965E-A742BE801E58 Q40776497-D86E88ED-604E-4DDF-8661-B44295BCE283 Q42846265-A680C631-B122-487C-A00F-F65F70D3AB14 Q57242776-41A902AE-FED5-42E3-B7E0-4143F33EE79C Q58709450-F9D9657E-D092-410C-9CC8-E16851BC3F8B

P2860

Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection

http://www.wikidata.org/entity/Q30419079

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Targeting pan-resistant bacter ...... ide expressed during infection

@ast

Targeting pan-resistant bacter ...... ide expressed during infection

@en

type

label

Targeting pan-resistant bacter ...... ide expressed during infection

@ast

Targeting pan-resistant bacter ...... ide expressed during infection

@en

prefLabel

Targeting pan-resistant bacter ...... ide expressed during infection

@ast

Targeting pan-resistant bacter ...... ide expressed during infection

@en

P1433

Q30419079-4BD1B585-A3FA-4028-AECA-B96B8298A8F0

P1476

Q30419079-6BC9F224-53C3-4ECB-8FF4-27BE55F4FDD3

P2093

Q30419079-0789DAFD-6A6F-43E3-A4BC-F85B419A7129

Q30419079-1D230A6B-7C89-4D7B-8A37-A6A051CADA95

Q30419079-250AB2C1-02F2-4D23-8D2B-9616D5D9ABFA

Q30419079-26D15E39-14CA-48FA-BC2F-578D3E2BB33D

Q30419079-275D6A43-603E-46AC-B444-2659FC9C6F39

Q30419079-2C16DC06-5434-4737-B9F7-81EA09983B5F

Q30419079-3E3DCAE1-0059-4FF8-8E5A-1EF20147BF8F

Q30419079-4399AA51-187A-46AB-94AC-92D625AD62CD

Q30419079-4BA1F481-A8F4-4412-8A85-72C87BE83482

Q30419079-60FA8968-C86F-4995-AFD7-45919BDC620C

P2860

Q30419079-109EA65B-6878-41EE-90E9-0ED025CF3A88

Q30419079-126C3DED-BCB7-4F21-B1BB-CACF3A4F1075

Q30419079-1C1762CF-4DBC-4AC3-877A-4BE9E81AD54A

Q30419079-237015E4-8D0C-49DF-BD9B-BCFD8D97516F

Q30419079-3DBA85F3-E81E-4AB1-9404-69CFF22225A3

Q30419079-3DD68831-279E-43D3-BF0A-EEC3174C2FB3

Q30419079-456B018E-D963-43C9-9E36-A02006A2674C

Q30419079-5F31EA01-BA43-4583-9B86-B421F9D540CC

Q30419079-5F344EA3-AEE5-4D82-9EDF-5A035441B52F

Q30419079-61FFE85F-155E-46BB-818C-5823A400DC9A

P304

Q30419079-7DDBFC41-DB82-4A4B-B26E-B9537366B5C3

P31

Q30419079-2E6BC448-EBF0-4DE6-A19F-EB84CC62B565

P356

Q30419079-776E4912-AC55-467F-945D-EEFEEF1268D8

P407

Q30419079-40C5FD2B-7A29-492B-9B7B-469216EF6B94

P433

Q30419079-5B84F99B-FCC9-41B5-B55F-AB2628BB47B3

P478

Q30419079-7EACD099-2DAE-4FC0-BBEA-D7BC2DB04F12

P577

Q30419079-9D46D8BB-E952-4EA2-8610-FCD0A57B79D2

P5875

Q30419079-6F85FD16-7D58-4E47-B9F2-AC4C8932DD41

P698

Q30419079-FD08960A-F843-4905-BAB9-CB25D327D166

P921

Q30419079-18E52970-8A28-486F-86B7-33F4A9AEC910

Q30419079-642904C2-2843-4831-AC9A-592AAE8D9598

P932

Q30419079-A84BACE0-1A70-4436-BFE4-21661F3A216A

P356

P1433

The Journal of Infectious Diseases

P1476

Targeting pan-resistant bacter ...... ide expressed during infection

@en

P2093

Alexander J McAdam

http://www.w3.org/2001/XMLSchema#string

Christina R Hermos

http://www.w3.org/2001/XMLSchema#string

Colette Cywes-Bentley

http://www.w3.org/2001/XMLSchema#string

Damien Roux

http://www.w3.org/2001/XMLSchema#string

David C Traficante

http://www.w3.org/2001/XMLSchema#string

David Skurnik

http://www.w3.org/2001/XMLSchema#string

Dennis Benedetti

http://www.w3.org/2001/XMLSchema#string

Erin L Thakkallapalli

http://www.w3.org/2001/XMLSchema#string

Gerald B Pier

http://www.w3.org/2001/XMLSchema#string

Gregory P Priebe

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis

The multifarious, multireplicon Burkholderia cepacia complex

Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes.

Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation.

The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation.

Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens

Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.

Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.

Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection

P304

1709-1718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIS254

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

205

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221976697

http://www.w3.org/2001/XMLSchema#string

P698

22448004

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

3415848

http://www.w3.org/2001/XMLSchema#string